Register Login

Biodesix Inc (BDSX)

Strobeck Matthew 🟢 acquired 13.2K shares (2 derivative) of BIODESIX INC (BDSX) at $6.46 Transaction Date: Jan 02, 2026 | Filing ID: 000073

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 10:26 p.m.

    🔍 Strobeck Matthew (Executive)

    Company: BIODESIX INC (BDSX)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 13,158

    Detailed Transactions and Holdings:

    • Acquired 6,804 shares of Restricted Stock Units (Derivative)
      Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,804.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
    • Acquired 6,354 shares of Stock Options (Right to Buy) at $6.46 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 6,354.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
    • F2: These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
    • F3: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
    • F4: This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer.

Search

News categories